Articles
https://doi.org/10.1038/s41591-020-01214-4

Life expectancy and mortality in 363 cities of Latin
America
Usama Bilal 1,2 ✉, Philipp Hessel 3, Carolina Perez-Ferrer4,5, Yvonne L. Michael1,2, Tania Alfaro 6,
Janeth Tenorio-Mucha 7, Amelia A. L. Friche8, Maria Fatima Pina 9,10, Alejandra Vives11,12,
Harrison Quick1,2, Marcio Alazraqui13, Daniel A. Rodriguez14, J. Jaime Miranda7, Ana V. Diez-Roux1,2
and the SALURBAL group
The concept of a so-called urban advantage in health ignores the possibility of heterogeneity in health outcomes across cities.
Using a harmonized dataset from the SALURBAL project, we describe variability and predictors of life expectancy and proportionate mortality in 363 cities across nine Latin American countries. Life expectancy differed substantially across cities within
the same country. Cause-specific mortality also varied across cities, with some causes of death (unintentional and violent injuries and deaths) showing large variation within countries, whereas other causes of death (communicable, maternal, neonatal
and nutritional, cancer, cardiovascular disease and other noncommunicable diseases) varied substantially between countries.
In multivariable mixed models, higher levels of education, water access and sanitation and less overcrowding were associated
with longer life expectancy, a relatively lower proportion of communicable, maternal, neonatal and nutritional deaths and a
higher proportion of deaths from cancer, cardiovascular disease and other noncommunicable diseases. These results highlight
considerable heterogeneity in life expectancy and causes of death across cities of Latin America, revealing modifiable factors
that could be amenable to urban policies aimed toward improving urban health in Latin America and more generally in other
urban environments.

O

ver 55% of the world’s population lives in urban areas
and this number is expected to reach almost 70% by 2050
(ref. 1), highlighting the importance of studying the drivers
of health in cities2. Even areas of the world that were traditionally
more rural (such as parts of Asia and Africa) are rapidly becoming
more urban1. In parallel with the growth of urban populations it
has become increasingly clear that designing and managing cities in
ways that protect the environment is key to achieving environmental sustainability. Moreover urban policies, such as the promotion of
active transportation or a shift toward renewable energies3, can have
considerable environmental and health co-benefits4, which support
a case for identifying the features of cities that are associated with
better population health and that can be modified with appropriate
policies5,6.
Despite growing urban populations, worldwide research on
the health effects of urban living is sparse and often inconsistent7.
Studies comparing urban to rural areas in different countries can
be difficult to interpret due to variations in definitions of urbanicity
across countries8,9. In addition, many of these studies do not identify specific features of urban living that are damaging or enhancing to health. Although many studies have documented differences
in life expectancy and cause-specific mortality across countries10–13
and, less frequently, across regions within countries14,15, few have
investigated variations in health across cities and the factors

associated with population health differences in these settings16,17.
To our knowledge, no previous study has explored the heterogeneity
in mortality and life expectancy outcomes in cities across multiple
countries using comparable data.
City governments can directly affect population health in their
municipalities, including mortality and environmental quality
through implementation of appropriate urban policies. International
organizations, such as UN-Habitat are increasingly calling for
city-based and local initiatives, as well as recognition of cities as
innovative, flexible and often progressive sites for policy-making
to achieve the Sustainable Development Goals2,9; however, these
actions must be based on evidence regarding what city-level factors are most important to health. Understanding the health consequences of urban growth, urban landscape features (such as urban
extent fragmentation) and city social features (such as access to
water) can help inform urban policies to promote health9.
As one of the most urbanized regions of the world and with many
diverse cities9, Latin America provides a unique setting in which to
investigate differences in life expectancy and causes of death across
cities, both within and between countries. Such analyses can offer
insights into the drivers of differences in population health across
cities and how urban policies might be used to enhance health
in cities globally. We used data compiled by the Salud Urbana en
América Latina (SALURBAL) study8,9 to: (1) describe the variability
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Fig. 1 | Variability in life expectancy at birth in 363 Latin American cities by country. Central line represents the median (50th percentile) city life
expectancy, box limits represent the 25th and 75th percentiles and whiskers represent 1.5× the extent of the interquartile range. AR, Argentina; BR, Brazil;
CL, Chile; CO, Colombia; CR, Costa Rica; MX, Mexico; PA, Panama; PE, Peru; SV, El Salvador.

in life expectancy and mortality profiles across Latin American cities in the period 2010–2016 and (2) investigate associations of city
characteristics and life expectancy and mortality profiles.

Results

Heterogeneity in life expectancy across Latin American cities.
Figures 1 and 2 show the distribution of life expectancy at birth in
each of the 363 cities for men and women (Extended Data Fig. 1
shows the distribution of life expectancy for men and women at
20, 40 and 60 years of age). There was considerable heterogeneity in life expectancy across cities within each country, even when
uncertainty in life expectancy estimation was accounted for: 41%
and 46% of the total variability in life expectancy was within countries, in women and men, respectively (Supplementary Table 1).
In men, the proportion of total variability that was within countries was higher for life expectancy at birth but was lower for life
expectancy at ages 40 and 60 years. In women the proportion of the
variability in life expectancy within countries did not vary as much
across age and high variability persisted at ages 20, 40 and 60 years
(Supplementary Table 1). We found that life expectancy at all ages,
for both sexes and for all cities, was highly reliable with a relative s.e.
(r.s.e. = s.e. / median life expectancy) <5% in all cases and <3% in
the case of life expectancy at birth (Supplementary Fig. 1).
We found an 8- and 14-year range in life expectancy among the
363 cities, with the lowest values at 74.4 (95% credible interval (CrI)
73.7 to 74.9) and 63.5 (95% CrI 61.7 to 65.2) and the highest values
at 82.7 (95% CrI 81.7 to 83.4) and 77.4 (95% CrI 75.3 to 78.9), in
women and men, respectively (Figs. 1 and 2; city-specific data are
available via the online interactive app https://drexel-uhc.shinyapps.
io/MS10/). Extended Data Fig. 2 compares the life expectancy of
each city with the life expectancy by income group for the 2012–
2016 period, obtained from the 2019 United Nations Development
Programme (UNDP) World Population Prospects18. For women,
city life expectancy ranged from 74.4 to 82.7 years, which is slightly
above that in middle-income countries (72.7 years) and slightly
below that in high-income countries (83.1 years). Larger variation was observed for men, with city life expectancy ranging from
63.5 to 77.4 years, which is below that in lower-middle-income
countries (65.4 years) and slightly below that of high-income countries (77.7 years).
Within countries, the largest ranges in life expectancy were
observed in Brazil and Peru for women (ranges of 6.4 years (75.6
to 82.0) and 6.6 years (74.4 to 81.0), respectively) and in Brazil
and Mexico for men (ranges of 8.6 years (66.3 to 74.9) and 10.4
years (63.6 to 74.0 years), respectively). Life expectancy also varied between countries, with Panama, Chile and Costa Rica having
the cities with the longest life expectancy (81–82 years for women
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and 75–77 years for men). Mexico, Brazil and Peru had cities with
the shortest life expectancy on average for women, at 77–78 years.
Mexico and Brazil also had the shortest life expectancies for men,
along with El Salvador, at 71 years on average. Figure 2 shows
detailed spatial patterns of life expectancy in Latin America, with a
North–South pattern in Brazil and Argentina and a coast-to-jungle
pattern in Peru.
Predictors of life expectancy in Latin American cities. Table 1
and Extended Data Fig. 3 show associations of urban characteristics
with life expectancy at birth in multivariable models, scaled using
s.d. to make coefficients comparable. Adjusted for other city-level
indicators, the social environment index (a composite index of four
indicators of area-level educational attainment, water and sewage access and overcrowding) predictive of longer life expectancy.
Specifically, a 1 × s.d. higher social environment index was associated with a 0.78 and 0.48-year longer life expectancy in men and
women, respectively. Moreover, we found that living in larger cities
was associated with slightly shorter life expectancy among men and
living in more fragmented cities (cities with a higher fragmentation
of their urban extent, measured using the density of distinct urban
patches) was associated with a longer life expectancy among both
men and women. We also found that men living in cities with rapid
population growth had longer life expectancy, but this association
was not robust to the choice of the time period of population growth
(Extended Data Fig. 4). Extended Data Fig. 3 shows the same set of
associations for life expectancy at ages 20, 40 and 60 years, showing
weaker associations especially in men. Extended Data Fig. 3 also
shows unadjusted associations, where we found that the four separate components of the social environment index are predictive of
life expectancy.
Heterogeneity in mortality profiles across Latin American cities.
There was considerable variability in proportionate mortality deaths
by a specific cause over total deaths by cause across cities (Fig. 3).
Proportionate mortality (the proportion of all deaths that is due to
a given group of causes) by communicable, maternal, neonatal and
nutritional (CMNN) conditions varied from 6% to 55%, proportionate mortality by cancer varied from 9% to 30%, proportionate
mortality by cardiovascular diseases (CVDs) and other noncommunicable diseases (NCDs) varied from 28% to 71%, proportionate mortality by unintentional injuries varied from 3% to 19% and
proportionate mortality by violent injuries varied from 0% to 20%
(Fig. 3, Extended Data Fig. 5 and Supplementary Table 2). CMNN,
cancer and CVD/NCDs deaths varied more between countries than
within countries (Supplementary Table 3; intraclass correlation
coefficient (ICC) = 80%, 71% and 64%), with Peruvian, Chilean and
Nature Medicine | VOL 27 | March 2021 | 463–470 | www.nature.com/naturemedicine
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Table 1 | Associations of city characteristics with life expectancy at birth among men and women in 363 Latin American cities
Variablea

s.d.

Men

Women

−0.09 (−0.2;0.03)

0.00 (−0.08;0.08)

0.43 (0.23;0.62)

0.22 (0.08;0.36)

−0.09 (−0.39;0.22)

−0.02 (−0.24;0.20)

City size

50% larger city

City growth

2.7% growth/5 years

Population density

4,145 population km

Fragmentation

0.3 urban patches km−2

0.28 (−0.02;0.58)

0.31 (0.10;0.53)

Street connectivity

6.4 intersections km−2

−0.27 (−0.85;0.31)

0.05 (−0.36;0.46)

Social environment index

1 × s.d.

0.78 (0.55;1.00)

0.48 (0.32;0.64)

b

b

−2

Coefficients are differences in life expectancy (95% confidence intervals (CIs)), obtained from a linear mixed model of life expectancy, adjusted for the percentage of the administrative area of the city
that is urbanized (Methods), with a random intercept for country, with all variables included in the same model. aVariables are defined in Methods and supplementary information. All variables are scaled
by their s.d., so their coefficient is interpreted as the difference in life expectancy per s.d. increase in the variable. bCity size was log transformed and its coefficients are interpreted as the increase in life
expectancy in cities that are 50% larger.
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Fig. 2 | Spatial distribution of life expectancy at birth by city in 363 Latin American cities. The maps show life expectancy at birth for women (left) and
men (right) in each city. The ranges (keys) are different for women and men.

Mexican cities having a higher proportionate mortality by CMNN,
cancer and CVD/NCDs, respectively, compared with other countries. However, injury deaths showed large within-country variability (ICC = 38% for both unintentional and violent injuries), with
cities ranging from 0% to 20% proportionate mortality by violent
injuries in Mexico, Colombia and Brazil and from 4% to 19% proportionate mortality by unintentional injuries in Peru and Brazil.
Variability in age-adjusted proportionate mortality (AAPM) was
similar (Extended Data Fig. 6), although within-country variability in violent deaths was reduced (ICC = 48%, compared to
38% without age-adjustment; Supplementary Table 3), whereas
within-country variability in unintentional injuries deaths was
increased (ICC = 24% compared to 38%).
Extended Data Fig. 7 shows the spatial distribution of proportionate mortality. CMNN, while highest in Peru overall, had
its highest levels specifically in cities of the Peruvian jungle.
Argentina, with relatively high levels of proportionate mortality by
CMNN, had a higher proportionate mortality in the northwestern
cities of the country. Proportionate mortality by cancer, highest
in Chile, was also high in Southern Brazil and in the Argentinian
Pampas. CVD/NCDs were highest in Mexico, specifically in the
center and northeastern parts of the country. Unintentional injuries were relatively high in cities in the Peruvian mountains and in
North and Central Brazil, whereas violent injuries were highest in
Nature Medicine | VOL 27 | March 2021 | 463–470 | www.nature.com/naturemedicine

North and Northeastern Brazil, Southern Mexico and the Pacific
coast of Colombia.
Predictors of cause-specific proportionate mortality in Latin
American cities. Higher attainment of the social environment
indicators (lower overcrowding, higher water and sewage access
and higher educational attainment) were associated with a lower
CMNN and injury proportionate mortality and a higher cancer and
CVD/NCDs proportionate mortality. Figure 4 shows the association of the social environment index with proportionate mortality
(left) and AAPM (right): from the lowest to medium levels of social
development, there is a sharp decrease in proportionate mortality
by CMNN (20% to 15%) and an increase in CVD/NCDs (54% to
56%) and cancer (13% to 16%). From the medium to the highest
levels, there is a further decrease in CMNN proportionate mortality
(15% to 10%), an increase in cancer proportionate mortality (from
16% to 23%) and a decrease in unintentional injuries and violent
injuries (from 7–8% to 4–5%). The pattern with AAPM was similar.
Associations with higher educational attainment, water and sewage
access and lower overcrowding were similar to the composite social
environment index (Extended Data Figs. 8 and 9). Specifically, overcrowding had a very strong and steep association with CMNN, with
proportionate mortality by CMNN around 13% at the lowest levels
of overcrowding and 21% at the highest levels.
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of the index. The white labels show proportionate mortality by each of the five causes by values of the social environment index (in five equal intervals).

Extended Data Figs. 8 and 9 also show proportionate mortality and AAPM, respectively, by other city-level factors. Cities with
a higher age-adjusted mortality rate have a higher violent injury
proportionate mortality and a lower cancer proportionate mortality. Larger cities have a higher violent injury proportionate mortality, although this association was not observed for the largest
cities in our sample. Cities with rapid growth have a higher CMNN
and injury proportionate mortality and a lower cancer and CVD/
NCDs proportionate mortality. Denser cities have a higher violent
injury proportionate mortality and CMNNs first increase but then
decrease with density, whereas cities with a less-connected street
network and a more fragmented urban extent have a lower CMNN
and higher CVD/NCDs proportionate mortality.
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Table 2 shows associations of each city-level predictor with proportionate mortality for each cause relative to CVD/NCD, adjusted
for all other predictors and age (Extended Data Fig. 10 shows a
comparison for different sets of adjustments). Cities with higher
all-cause age-adjusted mortality have relatively higher proportionate mortality due to violent injury, whereas larger cities have
higher violent injury proportionate mortality and lower unintentional injury proportionate mortality. Dense cities had more violent
deaths and less-fragmented and more-connected cities, along with
cities with lower values of the social environment index, had more
CMNN deaths, all relative to CVD/NCD deaths. While population
growth was not associated with proportionate mortality, in sensitivity analysis using population growth in the 5 years before the study
Nature Medicine | VOL 27 | March 2021 | 463–470 | www.nature.com/naturemedicine
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Table 2 | Rate ratio (95%) for each group of causes of death (compared to CVD/other NCDs) associated with a 1 × s.d. increase in
city-level factors, adjusted for all other city-level factors, the percentage of the administrative area of the city that is urbanized and
the percentage of the population aged 15 years or below and 65 years or above
Variable

s.d.a

CMNN

Cancer

CVD/NCDs
(reference
group)

Mortalityb

94.3 deaths per
100,000

0.99 (0.93;1.05)

0.88 (0.83;0.94)

1.00

1.01 (0.95;1.07)

City sizec

50% larger cityc

1.01 (0.95;1.08)

1.03 (0.97;1.10)

1.00

0.95 (0.89;1.01)

1.10 (1.03;1.18)

City growthb

2.7% growth in 5
years

1.01 (0.96;1.07)

0.99 (0.94;1.05)

1.00

1.02 (0.96;1.08)

1.02 (0.96;1.08)

Population densityb

4,145 population km−2

1.00 (0.95;1.05)

1.03 (0.98;1.09)

1.00

1.02 (0.97;1.07)

1.17 (1.11;1.23)

Fragmentationb

0.3 urban
patches km−2

0.86 (0.80;0.92)

0.96 (0.89;1.02)

1.00

0.96 (0.90;1.03)

1.04 (0.97;1.11)

Street connectivityb

6.4 intersections km−2

1.14 (1.00;1.30)

1.07 (0.95;1.22)

1.00

1.04 (0.91;1.18)

1.06 (0.93;1.21)

0.84 (0.80;0.89)

1.03 (0.97;1.08)

1.00

0.97 (0.92;1.02)

0.97 (0.92;1.02)

Social environment index 1 × s.d.

Unintentional

Violent

1.27 (1.20;1.35)

All variables are included in the same model. This analysis includes 362 cities, as Zarate-Campana in Argentina has no available street network data. bCoefficients are rate ratios (as compared to CVD/
NCDs) and 95% CIs, per s.d. increase in the variable. cCoefficients are rate ratios (as compared to CVD/NCDs) and 95% CIs, in a 50% larger city. aRefers to the scale of the variable (for example, mortality
coefficients are interpreted per 107.8 deaths/100,000 people increase or 1 × s.d. of age-adjusted mortality rate). Ref., reference group (CVD/NCDs).

time (rather than concurrent with the study time), we found that
population growth was associated with lower CMNN and cancer
proportionate mortality (Extended Data Fig. 4). Sensitivity analysis excluding cities with the highest proportion of ill-defined deaths
showed no difference in results (Extended Data Fig. 10).

Discussion

Our findings demonstrate that life expectancy and mortality profiles
are highly heterogeneous across Latin American cities. Life expectancy at birth ranges from 74–83 years and 63–77 years in women
and men, respectively. While countries such as Panama, Costa Rica
and Chile have higher levels of life expectancy, in many countries
there is large variability in life expectancy across cities within each
country, sometimes as large as a difference of 7–10 years, as is the
case with Mexico, Brazil, Colombia and Peru. We also found that
social environment variables were predictive of life expectancy.
The heterogeneity in mortality profiles between and within countries varied widely by cause. While NCDs were the most common
cause of death and injuries were the least common, the proportion
of deaths by each cause varied substantially across cities. We found
that CMNN, cancer and CVD/NCD deaths varied more between
countries and unintentional injuries and violent injuries deaths varied more within countries. We also documented several important
patterns regarding associations of city features with cause-specific
mortality. We found that large and/or dense cities had a higher
proportionate mortality by violent injuries and less-fragmented
and more-connected cities had a higher proportionate mortality by
CMNN. Cities with better social environment indicators had lower
CMNN, whereas the association with CVD/NCDs and cancer varied over the range of social environment values.
The usual conceptualization of the urban advantage in health7
leaves an open question of whether health outcomes are similar
across cities and whether there is a role for city-level factors as determinants of health5. We have shown that there is large variability in
life expectancy and proportionate mortality, even when considering
cities in the same country.
Few studies have examined life expectancy at the city level
across different countries. Cities in our sample with the lowest life
expectancy at birth for men (63 years in Acapulco, Mexico), had
life expectancies similar to Botswana and Myanmar, whereas the
lowest city life expectancies for women (74–75 years in Acapulco,
Acuña and Juarez in Mexico, Riohacha in Colombia and Chimbote
Nature Medicine | VOL 27 | March 2021 | 463–470 | www.nature.com/naturemedicine

in Peru) were similar to the life expectancy of cities in Egypt
and Bangladesh. Cities with the highest life expectancy for men
(77 years in Ica and Lima in Peru, San Jose in Costa Rica and Talca,
La Serena and Santiago in Chile) were similar to high-income countries such as Portugal and Slovenia, whereas the highest life expectancy for women (82–83 years in Los Angeles, Santiago, La Serena
and Valparaiso in Chile and David in Panama) was similar to the
United Kingdom and Germany (Fig. 2 shows a comparison with
life expectancy by World Bank income groups, all for 2012–2016,
obtained from the 2019 UNDP World Population Prospects)18.
With respect to mortality profiles, we observed heterogeneities
across cities that differed by cause. For example, the range of proportionate mortality by violent injuries varies from close to 0%,
similar to that of Italy or Greece, to around 20%, similar to rates
in Iraq13. Mortality by CVD/NCDs ranged from 28%, similar to
Togo or Madagascar, to 71%, similar to Serbia or Romania13. The
Global Burden of Disease study looked at variations between states
within both India14 and Mexico15, but has not done so at a city level.
While states are meaningful political units, cities can have more
pronounced effects on health and mortality profiles through local
urban policies19. The rise of municipalism and the coordinated
efforts of cities across the world, offers the opportunity to develop
tailored policies at the local level that draw strength from the specific particularities of each city, but that also acknowledge their connections to other cities or parts of the world20.
We found that social environment indicators, including education, access to water and sanitation and overcrowding, were
strongly associated with life expectancy. This association has
two potential explanations21: that these indicators are markers
of improved living conditions and health-promoting services
relevant to multiple causes of death across multiple ages or that
these indicators capture processes specific to certain causes of
death. For example improved sanitation and access to water are
linked to lower rates of diarrhea and other communicable diseases22, lower levels of overcrowding are linked to a lower rate of
respiratory infections23 and increased area-level socioeconomic
status is associated with lower cardiovascular disease mortality
in US counties24. We found that these associations were weaker
for life expectancy at ages 20, 40 and 60 years compared with life
expectancy at birth, which is consistent with other literature from
the region showing a lack of a social gradient in mortality for
the elderly25.
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Social environment variables also showed consistent associations
with proportionate mortality. Higher levels of education attainment
and water and sewage access and lower levels of overcrowding were
associated with a higher proportion of cancer and CVD/NCDs and
a lower proportion of CMNN. The higher proportion of NCDs in
areas with improved markers of social environment is consistent
with the epidemiological/demographic transition into stage 3 (ref.
26
), the stage of social development associated with an increase in
mortality related to NCDs, highlighting the need for better NCD
control strategies in these cities27.
Overall, cities with a better social environment had longer life
expectancy (and therefore, lower overall levels of mortality) and
higher mortality by NCDs, consistent with epidemiologic transition
models26. However, as has been noted28, later stages in the epidemiologic transition can also be characterized by large health inequities (which we have shown to be very wide in Latin America29) and
by large heterogeneities in the proportion of deaths from injuries28.
That we found no adjusted association of social environment indicators with violence mortality (and only a weak negative association with unintentional injuries) highlights that, at least for Latin
American cities, injury mortality occurs at all levels of the social
development spectrum.
We found that life expectancy was shorter for men living in large
cities, but found no association for women. We also found that
larger cities had a relatively higher proportionate mortality by violence compared with smaller cities. Given that in Latin America,
violent deaths are strongly concentrated among young men, both
results are consistent with a higher burden of violence in large cities. This is consistent with some previous research showing higher
rates of violent crime in large cities both in the United States30 and
in Brazil, Mexico and Colombia31. We also found that more fragmented cities had longer life expectancy and a relatively lower proportionate mortality by CMNN, whereas cities with more densely
connected street networks had proportionately higher CMNN.
This is consistent with previous research on the relationship of
the fragmentation of urban ecosystems and infectious diseases32,33.
Last, cities with high population density had a higher proportionate
mortality by violent injuries, especially comparing those of medium
density versus low density, similar to research in the United States
that found that increases in density at the low end of the spectrum
are associated with higher violence34.
This study has several strengths. First, we included 5 years of
data on all deaths and population of all 363 cities above 100,000
people in nine Latin American countries, representing 283.3 million people (almost half of the entire population of the region of
Latin America and the Caribbean). These countries represent a
wide variety of social and economic conditions, from lower-middle
to high-income countries35. This constitutes a comprehensive effort
to characterize life expectancies and mortality profiles across the
universe of cities of these countries in Latin America. Second, we
have harmonized and standardized mortality records in each city8
and have tried to correct several issues that are present in analyses of
vital registration records, including lack of complete coverage, using
city-specific corrections. Third, we have also used categorizations of
causes of death employed in previous studies, improving the generalizability of our results8. Last, we have examined these associations
using robust multilevel models, both univariable and multivariable,
including nonparametric models. Future studies using these data
will examine how various specific factors are related to changes
in life expectancy over time, including air pollution, measures of
income equality or characteristics of the healthcare system.
This study has a number of limitations. First, while we corrected
for potential under-reporting of deaths by estimating completeness at the city level, there is potential for this correction to not be
enough or to be overcorrecting our mortality rates (increasing them
spuriously). We implemented common demographic methods for
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the estimation of levels of coverage of mortality and used them in a
way that maximizes adherence to assumptions36, especially the lack
of migration assumption. Our analysis of proportionate mortality
data should be robust to these biases, given that our estimates provide associations for the relative increase in certain causes of death
compared to overall mortality, which should be robust to undercounting providing that there is consistency in the under-reporting
by cause of death. Second, the quality of data regarding age may also
be problematic, as there is reported age over-estimation in mortality records, age-underestimation in population estimations and age
heaping37. Third, we rely on the causes of death as coded in death
certificates, where some deaths are coded as ill-defined38; however,
we redistributed these to other causes using a proportional simple
imputation based on age, sex, country and year38,39. Our sensitivity
analysis to test the robustness of our results to a high proportion
of ill-defined deaths showed no changes to our main inferences.
Another limitation is the different timing in the measurement of
social environment measures, for which we rely on censuses conducted at different times in each country. Last, our analysis was
conducted at the city level, so inferences about more granular levels
(neighborhoods, households and individuals) are limited40.
There is large heterogeneity in life expectancy and mortality profiles across cities of Latin American countries. Population
growth and social environment indicators are positively associated
with life expectancy, whereas city size, growth and built and social
environment features are associated with different causes of death.
Characterizing heterogeneity of population health and factors that
influence health across cities is the first step toward identifying risk
factors that can be effectively modified by urban and health policies, as well as their implementation and continued monitoring for
the region.
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Methods

Study setting. We conducted this study as a part of the SALURBAL project8,9,
which has compiled and harmonized health, social and physical environment
data on all cities with a population above 100,000 in 11 Latin American countries
(Argentina, Brazil, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Mexico,
Nicaragua, Panama and Peru). The SALURBAL study protocol was approved by the
Drexel University Institutional Review Board (ID no. 1612005035).
Cities of 100,000 people or more in 2010 were identified by combining
information from the Atlas of Urban Expansion, census-based population data on
administratively defined cities in each country and inspection of built-up areas on
satellite maps8 Using this approach, 371 cities were identified and operationalized
as clusters of the smallest administrative units for which disaggregated vital
statistics data were available. More details on city selection and definition are
available elsewhere8.
For this study, we used data on 363 cities in nine countries for which mortality
and population data were available at the city level: Argentina, Brazil, Chile,
Colombia, Costa Rica, El Salvador, Mexico, Panama and Peru. We summed
deaths and population counts for each city during a 5-year period (2012–2016,
except for El Salvador, which was 2010–2014 owing to restricted data availability).
Nicaragua and Guatemala were excluded because of a lack of mortality data with
georeferenced location of residence.
Data sources. We obtained mortality data from vital registration systems in each
country. Mortality records included data on municipality of residence, age at death
and cause of death coded using the International Classification of Diseases v.10.
Population projections or estimations at the city level for every year from 2010 to
2016 by age were obtained from national census bureaus. Data on predictors were
obtained from vital statistics, population projections, censuses (latest available for
every country), the Global Urban Footprint Project (2012), Worldpop (2010) and
OpenStreetmap (2017). More details are available elsewhere8 and in Supplementary
Tables 4–6.
Vital registration data. We addressed three challenges of vital registration.
First, we imputed data with missing sex (~0.2%) and age (~0.5%) using a single
conditional imputation. We imputed sex in each record with missing sex using the
observed proportion of males in the same age (5-year groups) and cause of death
strata for each country year. The same procedure was used for imputing age using
sex and cause of death.
Second, we corrected for the lack of complete registration of all deaths at the
city level, using an ensemble of death distribution methods41–43, stratified by sex.
These methods estimate the degree of coverage of deaths using population by
age at two points (coinciding with the study period) and deaths in the period in
between. We estimated coverage using three different methods: generalized growth
balance (GGB)44, synthetic extinct generations (SEG)45 and the hybrid method41. To
address the assumption of lack of net migration, we used two strategies. First, we
obtained the average of the coverage estimates, an approach that has been proposed
to adequately account for migration flows to cities36,46. Specifically, we computed
the harmonic mean of the GGB, SEG and hybrid methods46. Second, we calculated
estimates of coverage for three age bands. First, we used the best-fitting age bands
as provided by the DDM R package47, a method used before in Ecuador46. Second,
we also used manually specified age bands, specifically the ages proposed by Hill36
(30–65 years) and Murray43 (50–70 years), as these are age ranges where migration
is lower than at younger ages. The combination of three methods and three age
bands resulted in nine estimates of completeness per city, which we incorporated
in our models as detailed below. Supplementary Fig. 2 shows the distribution of
estimates of completeness of death counts by city and country.
Third, we redistributed deaths assigned to ill-defined diseases or injuries
to specific causes of death38,39. We did this redistribution in three steps. First,
for every 5-year age group, sex, country and year, we obtained the observed
distribution of causes of death, diseases (CMNN, cancer and CVD/NCDs) and
injuries (unintentional and violent). Second, for all deaths by an ill-defined
disease in each 5-year age group, sex, country and year, we assigned a cause of
death (CMNN, cancer or CVD/NCDs) using a single multinomial draw, with
the observed probabilities from step 1. For all deaths by an injury of ill-defined
intent in each 5-year age group, sex, country and year, we assigned a cause of death
(unintentional or intentional) using a single multinomial draw, with the observed
probabilities from step 1. Supplementary Table 2 and Supplementary Fig. 3 show
the proportion of deaths by ill-defined diseases and by injuries of ill-defined intent
by city and country. Ill-defined diseases represented 3% of all deaths and ranged
from 0 to 32% by city, although 90% of the cities had <13% ill-defined deaths.
Ill-defined deaths were highest in Argentina, Brazil and El Salvador (6%, 4% and
15%, respectively). Injuries of ill-defined intent represented <0.1% of all deaths,
ranged from 0 to 28%, although all but four cities had <5% of all deaths due to
injuries of ill-defined intent.
City-level predictors. We purposively selected nine predictors available in routine
data sources and that also captured three dimensions potentially amenable to
urban policies: demographic features, urban form characteristics and social
environment characteristics. Demographic features included city size (population)
Nature Medicine | www.nature.com/naturemedicine

and city growth (population growth in the 5 years of the study). Age-adjusted
all-cause mortality rate (using the 2000–2025 World Health Organization
standard population) was also included as a covariate in analyses of proportionate
mortality by cause. To characterize urban form, we used population density
(population per area), fragmentation of the urban extent (density of urban patches)
and connectivity (density of street intersections). To characterize the social
environment, we used the proportion of the population aged 25 years or above
that completed primary education and the proportion of households that were
overcrowded, had water in the dwelling and connection to the sewage network.
We also created a social environment index as the sum of the z scores of education,
water access, sewage access and overcrowding (reversed). A higher level of the
social environment index is a proxy for improved social conditions. All features
refer to the administrative extent of the city. Supplementary Tables 4 and 5 show
detailed definitions, operationalization and data sources for all indicators and
Supplementary Table 7 shows a description by city size.
Estimation of life expectancy. Life expectancy is a widely used marker of the
health of populations, as it summarizes mortality across ages and is a number that
can be easily understood in terms of years of life10. To estimate life expectancy,
we obtained estimates of age- and sex-specific mortality rates using a Bayesian
Poisson model that draws information from country-level mortality patterns and
age-specific mortality patterns. This model also incorporates uncertainty from
the estimation of under-registration of death counts, following the approach of
Schmertmann and Gonzaga48.
We let yi(j)k and ni(j)k denote the number of deaths in age group k from city j of
country i, where k = 1,…17, i = 1,…9, j = 1,…Ji, and Ji denotes the number of cities
in our dataset that belong to country i. To model these death counts, we assume


yið jÞks  Pois cið jÞs nið jÞks λið jÞks
ð1Þ

where λi(j)ks denotes the city/age/sex-specific mortality rate and ci(j)s is a correction
factor that measures the estimated proportion of deaths observed for each city and
sex. Due to the potential for small counts in our data, we made use of Bayesian
models to produce more precise estimates of the λi(j)ks. First and foremost, we write
log λið jÞks ¼ β0ks þ αjs þ zið jÞks

ð2Þ

where β0ks denotes an age/sex-specific intercept term, αjs denotes a country-specific
random effect and zi(j)ks is a random effect that permits the flexibility for each
city to have its own trends in mortality across age groups. While sufficient data
exist to produce stable estimates of the β0k parameters without informative
prior structures, estimating the remaining parameters may require additional
considerations. For instance, some countries have very few cities (for example,
Costa Rica has only one city included in our study, Panama and El Salvador have
three cities each); thus, to prevent
overfitting we shrink the αjs toward each other by

assuming αjs  Norm 0; τ2s , where τ2s controls the degree of shrinkage. To model
I
the city-specific
random effects, however,
we require a more nuanced approach.
I
In particular, while we want to let zi(j)ks vary by both city and age, the mortality
schedules by age suggest that a simple linear trend in age would be inappropriate.
However, we would also like to avoid sudden sharp increases or decreases in the
zi(j)ks across age, instead favoring more smooth/gradual changes in age-specific
mortality rates at the city level. Thus, we consider the use of an autoregressive
structure for each city’s zi(j)ks where we assume
zið jÞ1s jσ 21s  Normð0; σ 21s Þfor age � group 0 � 1

ð3Þ

zið jÞks jzið jÞ;k�1;s σ 2k  Normðρs zið jÞ;k�1;s ; σ 2ks Þfor age � groups > 0 � 1

ð4Þ

where ρs denotes a between-age correlation parameter and the
parameters
facilitate between-city shrinkage in the zi(j)ks. Thus in our modeling
I approach, the
city-specific mortality rate for a given age group is assumed to be centered around
a value based on which country it belongs to ( exp β0ks þ αjs ) with deviations from
this trend being permitted when strong evidence
I exists (for example, greater than
expected death counts among consecutive age groups).
We account for potential undercounting by following the approach of
Schmertmann and Gonzaga48,49. We begin by calculating the nine completeness
estimates described above (GGB, SEG and the hybrid GGB–SEG, by the three
potential age bands, automatic, 30–65 and 50–70), which we denote c*ið jÞs;f for
f ¼ f1; ¼ ; 9g. We then let ϕi(j)s denote the harmonic mean (as suggested
by
I
46
I
),
Peralta


!�1
ϕið jÞs 1 � ϕið jÞs
X 1
ϕið jÞs ¼
and Kið jÞs ¼
�1
s2ið jÞs
c*ið jÞs;f
f
σ 2ks

where
s2ið jÞs ¼


X
c*ið jÞs;f � ϕið jÞs =ð9 � 1Þ
f
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represents the sample variance of the c*ið jÞs;f correction factors relative to their
harmonic mean. We then let the correction
factor in our model, ci(j)s, have a prior
I
distribution of the
 form:


cið jÞs  Beta Kið jÞs ϕið jÞs ; Kið jÞs 1 � ϕið jÞs ; which yields a prior whose expected
valueI is ϕi(j)s and variance is s2ið jÞs , as desired. It should be noted that our goal is not
necessarily to learn about theIci(j)s but rather to account for the uncertainty in our
estimate of the true proportion of undercounting in the data.
This model was fitted using iterative Markov chain Monte Carlo (MCMC)
using the JAGS program. The estimation for the model starts with 50,000 burn-in
MCMC iterations that allow the chain to converge, followed by 100,000 MCMC
iterations. To reduce autocorrelation we thinned these samples by a factor of 100
to obtain 1,000 complete sets. We obtained a sample of 1,000 complete sets of
age- and sex-specific mortality rates (λ) from these iterations. From this model,
we obtained a complete set of 1,000 age- and sex-specific mortality rates that were
used henceforth. Finally, we calculated a set of 1,000 life expectancies for each city
and sex using life tables, both at birth and at ages 20, 40 and 60 years, using the
DemoTools R package50 (lt_abridged function).

Mortality profiles. Mortality profiles by cause of death were operationalized using
cause-specific proportionate mortality, estimated as number of deaths in a specific
cause divided by the total number of deaths:
Deathsij
PMij ¼ PI
i¼1 Deathsij

Where PMij is the proportionate mortality for the ith cause in the jth city and
deathsij are the number of deaths due to the ith cause in the jth city. Deaths were
categorized using the Global Health Estimates classification51 and then grouped
into five categories: (1) CMNN; (2) cancer; (3) CVD/NCDs; (4) unintentional
injuries; and (5) violent injuries. Supplementary Table 8 contains a comprehensive
list of International Classification of Diseases codes included in each category.
In secondary analyses, we also calculated an AAPM, by using cause-specific
age-adjusted mortality rates (using the World Health Organization 2000–2025
population):
Age-adjusted mortality rateij
AAPMij ¼ PI
i¼1 Age-adjusted mortality rateij

In descriptive analysis, to account for the lack of complete registration of all
deaths, we upweighted deaths by the correction factor (corrected deaths = observed
deaths / coverage). For the multilevel models, we downweighed population by
the correction factor to avoid increasing the precision of our estimates artificially
(corrected population = observed population × coverage).
Statistical analysis. The main objectives of this analysis were to describe
heterogeneity in life expectancy and mortality profiles between Latin American
cities and to estimate associations with city-level factors.
To describe variability in life expectancy, we created graphical depictions of
life expectancy by city and country, showing the median and (where appropriate)
95% CrIs of life expectancy for each city. We also calculated and plotted the r.s.e., a
measure of the sampling variability of life expectancy. We considered an estimate
reliable if r.s.e. < 25%52.
We also decomposed the variability in life expectancy into: (1) differences
between the 1,000 iterations within each city; (2) differences between cities within
a country; and (3) differences between countries using a three-level linear mixed
model with life expectancy as the dependent variable and a random intercept for
country and city:
Life Expectancy ijk ¼ α000 þ μ00k þ μ0jk þ ϵijk
μ00k  N ð0; τ000 Þ; μ0jk  N ð0; τ00 Þ; ϵijk  N ð0; σ 2 Þ;

Where life expectancyijk is the life expectancy for each ith iteration in the jth city in
the kth country, α000 is the overall mean life expectancy, μ00k is the deviation of each
country mean from the overall mean, μ0jk is the deviation of each city’s mean from
the country mean and εijk is the deviation for each iteration from the city mean.
These three random effects (country random intercept, city random intercept
and iteration residuals) are distributed normally with variances τ000, τ00 and σ2,
respectively. We calculated how much of the total variance (τ000 + τ00 + σ2) was at the
iteration level (σ2 / total variance), city level (τ00 / total variance) and country level
(τ000 / total variance). The linear mixed model to decompose variance was weighted
by the population of each city at baseline. We also computed ranges (max–min) for
life expectancy for each country, age and sex combination, to assess the variability
for specific countries.
To describe heterogeneity in mortality profiles across cities we created
graphical depictions of proportionate mortality and computed ICCs to describe
between- versus within-country variability, using a linear mixed model with each
proportionate mortality as the outcome and a random intercept for country.
To estimate the univariable association of city-level predictors with life
expectancy, we ran set of a linear mixed models with life expectancy as the

outcome, a random intercept for country and a single predictor in each model.
This model provides a descriptive look at the variation in life expectancy by levels
of city size, physical environment and social environment variables. The linear
mixed model was run 1,000 times (with the 1,000 estimated life expectancies for
each city) and then coefficients were pooled using Rubin’s formula53. We also ran
a multivariable model with all urban form variables and the social environment
index. This model provides a description of the variation in life expectancy by
levels of each predictor, adjusted for all other predictors.
We examined the association of city-level factors with proportionate mortality
using two approaches. First, we used a nonparametric approach to describe the
association of each city-level factor with proportionate mortality by each group
of causes of death. We computed a LOWESS smoother of each proportionate
mortality on the city-level factor. We then created stacked area plots showing
the estimated levels of proportionate mortality for the range of levels of the
city-level predictor.
Second, to provide an estimate of the strength of these associations, we fitted
a three-level negative binomial multilevel model for aggregated data, where each
observation was a cause of death–city–country combination, with an offset for
log(population), a random intercept for city and country. The model includes a
set of four indicator variables for cause of death, the variable of interest and an
interaction term between causes of death and the exposure. The exponentiated
interaction coefficients represent the relative increase in the proportion of
deaths by a specific cause as compared to CVD/NCDs per one-unit increase in
the predictor. We fitted these models at different adjustment levels: (1) a model
with each predictor investigated separately (univariable model); (2) a univariable
model + adjustment for the percentage of the population under 15 and above 65
(age-adjusted univariable model); (3) a univariable model adjusted for age and
all-cause mortality, to evaluate the sensitivity of the estimates to heterogeneity
in the absolute levels of mortality rates; and (4) a multivariable model with all
predictors included in the same model, along with age. In the multivariable
models we included only the social environment index instead of including all
social environment indicators to avoid collinearity between social environment
indicators.
In all models above, and to make coefficients comparable, all variables were
centered by their overall mean scaled by their overall s.d., except for population,
which was log transformed. All analyses that used built environment variables
(density, fragmentation, connectivity) were adjusted for the proportion of the
administrative area that is urbanized (covered by urban patches8), to avoid
measurement misclassification of built environment variables due to the definition of
the administrative area and to standardize cities by the size of the administrative area.
We ran two secondary analyses. First, we repeated the analysis in the restricted
set of cities in which we had data on population growth 5 years before the study
period, instead of concurrent with the study period, to compare associations of
population growth during and before the study period. Second, we ran the analysis
of predictors of proportionate mortality in the restricted set of cities with a lower
proportion of ill-defined deaths (defined as <90th percentile or 13% ill-defined
deaths).
We do not report P values to prevent ‘P hacking’ and as our goal was not to test
hypotheses but rather to report point estimates and levels of precision by the 95%
CI.40 Data harmonization and cleaning was conducted in R v.4.0.0 and SAS v.9.2.
All analyses were conducted in R v.4.0.0 and JAGS v.4.
Reporting Summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.

Data availability

Life expectancy and proportionate mortality data with city identifiers are freely
available from the interactive app at https://drexel-uhc.shinyapps.io/MS10/.
Vital registration data for Brazil, Chile, Colombia and Mexico were downloaded
from publicly available repositories from statistical agencies in each country.
Vital registration data for Argentina, Costa Rica, El Salvador, Panama and
Peru were obtained directly from statistical agencies in each country. A link to
these agency websites can be accessed via https://drexel.edu/lac/data-evidence/
data-acknowledgements/. Source data are provided with this paper.

Code availability

Code used in this study is available at https://github.com/usamabilal/
SALURBAL_MS10.
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Extended Data Fig. 1 | See next page for caption.

Nature Medicine | www.nature.com/naturemedicine

NATURE MEDICInE

Articles

Extended Data Fig. 1 | Variability in Life Expectancy at Birth, Ages 20, 40 and 60, in 363 Latin American cities by Country. Solid triangles represent the
life expectancy at the country level for 2012–2016 (2010–2014 for El Salvador), as obtained from UNDP’s World Population Prospects (2019 version).
The boxplot’s central line represents the median (50th percentile) city life expectancy, box limits represent the 25th and 75th percentiles, and whiskers
represent 1.5 times the extent of the interquartile range. AR: Argentina, BR: Brazil, CL: Chile, CO: Colombia, CR: Costa Rica, MX: Mexico, PA: Panama,
PE: Peru, SV: El Salvador.
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Extended Data Fig. 2 | Life expectancy at birth in 363 Latin American cities and reference lines for 2012–2016 life expectancy by income group. Dashed
lines represent life expectancy for World Bank income groups for 2012–2016, obtained from UNDP’s World Population Prospects (2019 version). Points
represent life expectancy at birth in each city and error bars represent the 95% credible intervals of life expectancy at birth in each city.
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Extended Data Fig. 3 | Results of the multivariable model with life expectancy at birth, 20, 40 and 60 years of age in 363 Latin American cities. Shown
are regression coefficients and 95% confidence intervals. Horizontal dashed line represents the null effect.
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Extended Data Fig. 4 | Results of secondary analysis using city growth in the 5 years previous to study period (instead of concurrent), in 363 Latin
American cities. Shown are regression coefficients and 95% confidence intervals. Horizontal dashed line represents the null effect.
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Extended Data Fig. 5 | Variability in Proportionate Mortality in 363 Latin American Cities. Each dot represents a city.
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Extended Data Fig. 6 | Age-adjusted proportionate mortality by city in 363 cities of 9 Latin American countries. Each column is a city, with each color
representing the proportion of deaths due to each cause. Cities are grouped in countries. Countries are sorted by the overall proportion of violent deaths in
the country, and cities are sorted within country by the proportion of violent deaths in each city. CVD and other NCDs: cardiovascular diseases and other
non-communicable diseases.

Nature Medicine | www.nature.com/naturemedicine

NATURE MEDICInE

Extended Data Fig. 7 | Spatial distribution of proportionate mortality in 363 Latin American cities.
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Extended Data Fig. 8 | Predictors Proportionate Mortality by 5 causes in 363 Latin American Cities. The range of the horizontal axis goes from the
minimum to the maximum observed value of each indicator. Ticks at the bottom of each plot represent observations (cities) with that value of each
indicator. The white labels show proportionate mortality by each of the 5 causes by values of each indicator in 5 equal intervals. CVD and other NCDs:
cardiovascular diseases and other non-communicable diseases.

Nature Medicine | www.nature.com/naturemedicine

Articles

NATURE MEDICInE
100%

Mortality Levels

75%

24.7% 19.9%

13.7%

16.2%

100%

14.0%

58.6%

60.4%

75%

75%

50%

50%

25%

5.8%

5.9%

6.0%

3.7%

4.4%

5.5%

6.3%
7.0%

Proportionate Mortality

12.6% 14.0%

18.5% 18.5%

18.1%

18.9%

57.2% 56.9%

59.0%

100%

13.0% 13.0%

13.6%

14.1% 14.6%

18.3% 18.6%

18.6%

20.2%

0%

5.9%

5.3%

4.8%

4.9%

5.8%

5.3%

5.0%

4.5%

5.5%

4.7%
4.7%

75%

50%

50%

4.5%

5.4%

5.4%

4.6%
4.0%

100%

Educational Attainment

75%

75%

50%

50%

16.1%

57.0%

14.2%

13.0% 10.0%

18.4%

19.2%

56.2%

58.0% 61.0%

100%

13.3%

13.1% 12.6%

16.6% 18.1%

18.2%

17.1% 15.4%

58.3%

58.2%

4.3%

3.0%
0%
10
20
30
40
Intersection Density (intersections/km2)

0%

6.5%

6.0%

7.9%

100%

75%

50%

50%

5.8%

6.5%

5.3%

4.1%

5.4%
3.7%

0%
50
60
70
80
90
% with Completed primary Education or Above

Cause

75%

75%

50%

50%

5.8%

7.6%

7.1%

5.9%

6.6%

7.4%

4.3%

5.0%

5.2%

Water Access

100%

19.6% 16.9%

15.2%

12.5% 12.4%

14.3%

15.2%

16.8% 19.6%

57.5% 58.8%

59.3%

13.8%

0%

100%

75%

75%

50%

50%

25%

0%
40
60
80
% HHs with Piped Water in the Household

0%

5.4%
3.8%

6.0%

6.2%

5.8%

5.9%

4.0%

4.1%

5.1%

5.4%

Communicable/Maternal/Neonatal/Nutritional

Cancer

Unintentional Injuries

Violent Injuries

19.2%

52.7%

12.1%

21.0%

8.2%

100%

100%

22.0%

75%

75%

50%

50%

55.4% 59.1%

25%

5.9%

6.1%

5.6%

5.3%

5.5%

4.1%

5.3%

6.2%

6.2%

5.2%

0%
10000
20000
30000
Population Density (Population/km2)

25%

0%

17.9%

16.3%

25%

59.8% 56.7%

25%

19.0%

58.5% 55.4%

0%
−5
0
5
10
15
% Growth in Population over 5 years

75%

25%
6.4%

5.7%

Population Density
12.5% 15.3%

25%

0%

100%

59.5%

25%

19.9%

25%

100%

13.6% 13.0%

56.6% 55.9%

57.9%

0%
200K 500K 1M 2M 5M 10M
Population at Baseline (log scale)

13.5% 13.9%

25%

6.1%

Population Growth

55.5%

25%

0%

58.3%

6.3%

59.0%
56.3%

75%

25%

13.3%
22.5%

50%
57.0%

19.6%

25%

9.1%

Street Connectivity

57.5% 58.2%

100%

Sewage Access

100%

14.1% 14.5%

14.9%

13.9% 11.7%

15.5% 17.5%

18.2%

17.5% 19.5%

57.6% 55.7%

55.6%

58.1% 58.5%

6.3%

6.0%

6.1%

5.7%

6.2%

6.0%

5.2%

4.3%

4.6%

14.0% 12.3%

11.7%

18.1% 18.8%

18.4%

56.7% 58.6%

59.4%

0%

100%

75%

50%

50%

19.5%

21.0%

57.5%

55.9%

25%

6.1%

5.7%

5.7%

5.7%

5.1%

4.6%

4.8%

4.3%

5.5%
3.5%

0.5
1.0
1.5
Patch Density (Patches/km2)

Overcrowding
13.4% 12.3%

13.6%

18.3%

15.3%

20.4%

0%

100%
16.4% 19.2%

14.9%

15.2%

75%

50%
60.6%

58.9% 55.7%

25%

25%

0%

75%

50%

55.2% 58.8%

0%
25
50
75
% HHs with Connection to the Sewage Network

100%
12.9% 14.1%

25%

75%

25%

6.6%

Fragmentation

6.0%

5.8%

6.2%

5.7%

5.4%

5.0%

4.8%

4.4%

4.2%

4.5%

Proportionate Mortality

75%

12.2%

5.3%

0%
500 600 700 800 900
Age−Adjusted All−Cause Mortality

100%

100%

13.1% 14.1%

61.3%

25%

0%

City Size

13.3%

50%
54.6% 55.9%

100%

12.4% 10.9%

Proportionate Mortality

Proportionate Mortality

11.2% 14.0%

0%
5
10
15
20
% Overcrowded HHs (>3 people per room)

CVD and other NCDs

Extended Data Fig. 9 | Predictors of Age-Adjusted Proportionate Mortality by 5 causes in 363 Latin American Cities. The range of the horizontal axis
goes from the minimum to the maximum observed value of each indicator. Ticks at the bottom of each plot represent observations (cities) with that value
of each indicator. The white labels show proportionate mortality by each of the 5 causes by values of each indicator in 5 equal intervals. CVD and other
NCDs: cardiovascular diseases and other non-communicable diseases.
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Extended Data Fig. 10 | Rate Ratio for each group of causes of death (compared to CVD/Other NCDs) associated with a 1SD increase in city-level
factors for six different levels of adjustment in 363 Latin American cities. Coefficients are Rate Ratios (As compared to CVD/NCDs), and error bars
are their corresponding and 95% CIs, per standard deviation increase in each variable (except for city size, where they correspond to a 50% larger city).
Univariable model contains each variable in a different model, adjusted for % built-up (see methods). Univariable models adjusted for age contain a
covariable for % under 15 and % above 65, and univariable models adjusted for mortality contain a covariable for all-cause age-adjusted mortality rate.
Multivariable models contain all predictors in the same model. The model restricted by % ill-defined deaths restricts the analysis to cities with <13%
ill-defined deaths (90th percentile).
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